BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zona Pellucida

Below is an extended Zona Pellucida patents listing. Click here to return to the Zona Pellucida main in depth entry.

Patents :

US Patent No.Title
7399848 Polynucleotides encoding growth differentiation factor-8
7417066 Inhibitors of soluble adenylate cyclase
7422896 Compositions for DNA mediated gene silencing
7425445 Modulators that promote cell surface expression of odorant receptors
7425448 Cardiomyocyte precursors from human embryonic stem cells
7425617 Antibodies to the cell cycle regulatory protein p16
7426441 Methods for determining renal toxins
7427486 Mullerian inhibiting substance levels and ovarian response
7429450 HIP1 cancer markers
7429490 Tissue engineered uterus
7429690 Transgenic bovines having reduced prion protein production
7416874 Recombinant bacterial phytases and uses thereof
7415358 Molecular toxicology modeling
7414170 Transgenic bovines capable of human antibody production
7402728 Transgenic mice expressing human CD20 and/or CD16
7405036 Process for reducing pathogens in a biological sample and removing a sample pellet from a sample tube
7405202 CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
7407762 Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
7407763 Systems and methods for detecting and regulating metastasis
7407802 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
7407933 Drug containing angiotensin convertase
7410798 Culture system for rapid expansion of human embryonic stem cells
7413861 Methods for predicting increase sperm ejaculate in a varicocele associated fertility patient
7413904 Human embryonic stem cells having genetic modifications
7432057 Genetic test for PSE-susceptible turkeys
7432066 Non-invasive enzyme screen for tissue remodeling associated conditions
7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
7446239 SCA2 knockout animal and methods of use
7446240 Method for the production of porcine nuclear transfer embryos
7447594 Molecular cardiotoxicology modeling
7449459 Inhibitors of soluble adenylate cyclase
7452677 Monoclonal antibody capable of binding integrin alpha 10 beta 1
7452706 Recombinant bacterial phytases and uses thereof
7452718 Direct differentiation method for making cardiomyocytes from human embryonic stem cells
7452977 Antibody to a kinase capable of site-specific phosphorylation of I.kappa.B.alpha.
7453021 Transgenic animal model for degenerative diseases of cartilage
7445896 Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
7442548 Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid
7442513 Method of screening for agents that modulate a homer signaling pathway
7432067 Methods of detection of MATER protein autoantibodies
7432097 Phytases, nucleic acids encoding them and methods of making and using them
7432098 Phytases and methods for making and using them
7432104 Methods for the culture of human embryonic stem cells on human feeder cells
7432414 Transgenic mouse having an amyloid precursor protein with a modified beta secretase cleavage site
7432415 Unactivated oocytes as cytoplast recipients for nonprimate mammalian and pig nuclear transfer
7439024 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
7439039 Assays for novel serotonin transporter (SERT) blockers
7439063 Neuroprotective synergy of erythropoietin and insulin-like growth factors
7439221 Methods and compositions for modulating gamete adhesion
7455983 Medium for growing human embryonic stem cells

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.